PepGen Ownership | Who Owns PepGen?
PepGen Ownership Summary
PepGen is owned by 70.91% institutional investors, 0.27% insiders, and 28.82% retail investors. Ra capital management is the largest institutional shareholder, holding 32.64% of PEPG shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.51% of its assets in PepGen shares.
PEPG Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | PepGen | 70.91% | 0.27% | 28.82% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 10.69M | 32.64% | $11.87M |
Point72 asset management | 2.76M | 8.43% | $3.06M |
Frazier life sciences management | 1.50M | 5.24% | $23.98M |
Viking global investors lp | 1.48M | 4.53% | $1.65M |
Adage capital partners gp | 1.35M | 4.12% | $1.50M |
Blackrock | 1.04M | 3.62% | $16.58M |
Vanguard group | 912.67K | 2.80% | $3.46M |
Laurion capital management lp | 810.76K | 2.48% | $899.95K |
Blackrock funding, inc. /de | 648.02K | 1.98% | $719.30K |
Geode capital management | 372.86K | 1.14% | $1.41M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Frazier life sciences management | 1.50M | 1.12% | $23.98M |
Ra capital management | 10.69M | 0.20% | $11.87M |
Opaleye management | 110.00K | 0.07% | $416.90K |
Prosight management, lp | 243.98K | 0.07% | $270.82K |
Artal group | 113.32K | 0.05% | $1.81M |
Sphera funds management | 156.47K | 0.04% | $173.68K |
Ikarian capital | 150.00K | 0.03% | $166.50K |
Laurion capital management lp | 810.76K | 0.02% | $899.95K |
Suvretta capital management | 300.00K | 0.01% | $333.00K |
Bridgeway capital management | 98.90K | 0.01% | $374.83K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 1.04M | 0.00% | 257.32K |
Prosight management, lp | 243.98K | 0.07% | 243.98K |
Invesco | 231.06K | 0.00% | 231.06K |
Sphera funds management | 156.47K | 0.04% | 156.47K |
Millennium management | 156.64K | 0.00% | 142.81K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | - | - | -3.19M |
Suvretta capital management | 300.00K | 0.01% | -1.36M |
Perceptive advisors | - | - | -829.54K |
Orbimed advisors | - | - | -653.02K |
Blackrock funding, inc. /de | 648.02K | - | -646.23K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Prosight management, lp | 243.98K | 0.07% | 243.98K | $270.82K |
Invesco | 231.06K | 0.00% | 231.06K | $3.69M |
Sphera funds management | 156.47K | 0.04% | 156.47K | $173.68K |
Rbf capital | 100.00K | 0.01% | 100.00K | $111.00K |
Qube research | 73.00K | 0.00% | 73.00K | $81.03K |
Sold Out
Holder | Change |
---|---|
Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
Eversource wealth advisors | -1.00 |
Nelson, van denburg & campbell wealth management group | -2.00 |
Capital performance advisors llp | -13.00 |
Sterling capital management | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 51 | -29.17% | 23,223,347 | -8.27% | 70 | 1.18% | 21 | -47.50% | 20 | 17.65% |
Mar 31, 2025 | 71 | 18.33% | 25,307,046 | 1.27% | 77 | 1.32% | 40 | 29.03% | 17 | 30.77% |
Dec 31, 2024 | 56 | -8.20% | 21,470,858 | -15.25% | 65 | 1.09% | 27 | -15.63% | 13 | -7.14% |
Sep 30, 2024 | 61 | 1.67% | 25,334,214 | 0.74% | 77 | 1.01% | 32 | -11.11% | 14 | - |
Jun 30, 2024 | 60 | 9.09% | 25,149,159 | 1.88% | 87 | 1.18% | 36 | 2.86% | 14 | 7.69% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 492.80K | 1.51% | - |
Vanguard Total Stock Mkt Idx Inv | 472.39K | 1.44% | -10.32K |
Biotech Growth Ord | 409.12K | 1.25% | - |
Invesco Dorsey Wright SmallCap Momt ETF | 223.00K | 0.68% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 198.86K | 0.61% | -90.61K |
iShares Biotechnology ETF | 176.47K | 0.54% | 1.50K |
Fidelity Small Cap Index | 155.98K | 0.48% | - |
Vanguard Balanced Index Inv | 148.11K | 0.45% | - |
Fidelity Extended Market Index | 93.21K | 0.28% | -243.00 |
State St Russell Sm/Mid Cp® Indx NL Cl C | 90.99K | 0.28% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 30, 2025 | STRECK PAUL | EVP, Head of R&D | Buy | $10.39K |
Apr 17, 2025 | McArthur James G | President and CEO | Buy | $13.55K |
Apr 08, 2025 | McArthur James G | President and CEO | Buy | $47.73K |
Feb 26, 2025 | DeLena Mary Beth | General Counsel | Sell | $2.41K |
Feb 26, 2025 | Donnelly Noel | Chief Financial Officer | Sell | $2.57K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 3 | - |
2025 Q1 | - | 2 |
2024 Q3 | - | 7 |
2024 Q2 | - | 6 |
2024 Q1 | 1 | - |
PEPG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools